EMULATE, INC.

Profile

Company Names

EMULATE, INC.

Addresses

27 DRYDOCK AVENUE, 5TH FLOOR, BOSTON, MA 02210

27 DRYDOCK AVENUE, 5TH FLOOR, BOSTON, MA 02210

222 HURLEY STREET, CAMBRIDGE, MA 02141

Phone Numbers

617-704-9222
508-843-5324

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$182,265,736.00

Number of Funding Rounds:

7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2021-08-23 
$57,499,997.00 
$57,499,997.00 
$0.00 
Equity 
6
2020-03-06 
$19,275,000.00 
$20,000,000.00 
$725,000.00 
Debt 
5
2019-08-01 
$27,994,991.00 
$50,000,000.00 
$22,005,009.00 
Equity 
4
2018-06-06 
$35,999,998.00 
$35,999,998.00 
$0.00 
Equity 
3
2017-10-26 
$745,750.00 
INDEFINITE 
INDEFINITE 
 
2
2016-03-14 
$28,750,000.00 
$45,000,000.00 
$16,250,000.00 
Equity 
1
2014-07-11 
$12,000,000.00 
$12,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
JAMES 
COON 
EXECUTIVE OFFICER, DIRECTOR
EMULATE, INC.
JAMES 
DAVID 
COON 
EXECUTIVE OFFICER, DIRECTOR
EMULATE, INC.
JAMES 
 
CORBETT 
EXECUTIVE OFFICER, DIRECTOR
BAY EQUITY LLC   |  VERTOS MEDICAL INC   |  ALUCENT MEDICAL, INC.   |  BRANCHPOINT TECHNOLOGIES   |  EMULATE, INC.   |  ALUCENT BIOMEDICAL, INC.
HARMINDER 
 
DHALIWAL 
EXECUTIVE OFFICER
EMULATE, INC.
MICHAEL 
 
EGHOLM 
DIRECTOR
EMULATE, INC.   |  ISOPLEXIS CORP   |  ABBRATECH HOLDINGS LLC
GERALDINE 
 
HAMILTON 
EXECUTIVE OFFICER, DIRECTOR
EMULATE, INC.
GERALDINE 
A. 
HAMILTON 
EXECUTIVE OFFICER, DIRECTOR
EMULATE, INC.
DONALD 
 
INGBER 
DIRECTOR
EMULATE, INC.   |  UNRAVEL BIOSCIENCES, INC.   |  STATADX, INC.
SCOTT 
 
KANTOR 
EXECUTIVE OFFICER
EMULATE, INC.
SHARON 
 
KEDAR 
DIRECTOR
908 DEVICES INC.   |  ULTIVUE, INC.   |  EMULATE, INC.   |  ISOPLEXIS CORP
SANDY 
 
LAZZARI 
EXECUTIVE OFFICER
EMULATE, INC.   |  ABATA THERAPEUTICS, INC.
DANIEL 
 
LEVNER 
EXECUTIVE OFFICER, DIRECTOR
EMULATE, INC.
MARTIN 
 
MADAUS 
DIRECTOR
QUANTERIX CORP   |  JAGUAR HOLDING CO I   |  EMULATE, INC.   |  SYNTIS BIO, INC.
SHLOMO 
 
MELMED 
DIRECTOR
EMULATE, INC.   |  QUANTAVERSE LLC   |  PRECISION IBD, INC.   |  PROMETHEUS BIOSCIENCES, INC.   |  VISBY MEDICAL, INC.
ERIC 
 
MOESSINGER 
DIRECTOR
EMULATE, INC.   |  PULSE THERAPEUTICS, INC.   |  MUSE BIOTECHNOLOGY, INC.   |  SQZ BIOTECHNOLOGIES CO   |  SEROTINY, INC.   |  EUPHRATES VASCULAR, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  VISBY MEDICAL, INC.   |  PARTILLION BIOSCIENCE CORP   |  DRAGON VASCULAR, INC.
MONIQUE 
 
NOEL 
EXECUTIVE OFFICER
EMULATE, INC.
LEWIS 
 
ROWE 
EXECUTIVE OFFICER
EMULATE, INC.
ANDREW 
 
STEVENSON 
DIRECTOR
INTREX GLOBAL SOURCING, LLC   |  FAYERWEATHER FUND 1, L.P.   |  OPSONIX, INC.   |  EMULATE, INC.   |  FAYERWEATHER FUND MATTERHORN, L.P.   |  FAYERWEATHER FUND EIGER, L.P.   |  REDWOOD MATERIALS, INC.   |  ULTIVUE, INC.   |  ADAPTIVE SURFACE TECHNOLOGIES, INC.
AARON 
 
VANDEVENDER 
DIRECTOR
MODUMETAL INC   |  EMULATE, INC.   |  PSIQUANTUM, CORP.
LARRY 
 
WEISS 
EXECUTIVE OFFICER
SYMBIOME, INC.   |  EMULATE, INC.
GREGORY 
D. 
WILLIAMS 
EXECUTIVE OFFICER
EMULATE, INC.   |  TANTALUS SYSTEMS HOLDING INC.
FRANKLIN 
 
WITNEY 
DIRECTOR
EMULATE, INC.
FRANKLIN 
R. 
WITNEY 
DIRECTOR
EMULATE, INC.   |  TELESIS BIO INC.
HANSJOERG 
 
WYSS 
DIRECTOR
EMULATE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-09-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-23 
2020-03-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-03-06 
2019-08-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-01 
2018-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-06 
2017-11-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2017-10-26 
2016-03-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-14 
2014-07-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-07-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#